本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fortress Biotech Inc Series A P

14.40
+0.01000.07%
成交量:1,885.00
成交額:2.71萬
市值:4,935.02萬
市盈率:-49.15
高:14.48
開:14.28
低:14.28
收:14.39
52周最高:14.64
52周最低:5.60
股本:342.71萬
流通股本:342.71萬
量比:0.20
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-0.2930
每股收益(LYR):-2.6890
淨資產收益率:-746.25%
總資產收益率:-32.37%
市淨率:2.22
市盈率(LYR):-5.36

資料載入中...

2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/27

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/19

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

SEC問詢函

Form CORRESP - Correspondence
2023/07/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report